© 2021 MJH Life Sciences™ and Urology Times. All rights reserved.
Statin use linked with better outcomes in patients starting ADT for prostate cancer
February 8, 2021
Urology Times staff
Urology Times staff
“We continue to see a building story of benefit of statin medications in men who have prostate cancer,” says Robert J. Hamilton, MD, MPH.
In this interview, Robert J. Hamilton, MD, MPH, discusses findings from a recent study published in European Urology titled, “The Association Between Statin Use and Outcomes in Patients Initiating Androgen Deprivation Therapy,” for which he served as a study author. Hamilton is an associate professor of urology at the University of Toronto.
More videos:
Clinical care pathway demonstrates efficacy for patients with overactive bladder
Analysis underscores importance of pretreatment urine cultures in patients with recurrent UTI
Related Content:
